New York, Sep 22 (PTI): Recently World Health Chief, Tedros Adhanom Ghebreyesus passed a statement. He said that the decision of the nation to resume COVID-19 vaccine shipments is an important advancement. To support the goal to reach vaccinations all over the globe to 40 per cent by the end of the year.
Pic: Dr. Tedros Adhanom Ghebreyesus, WHO Director-General
COVAX is a a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the WHO. On Monday, the nation will resume the export of surplus COVID-19 vaccines to meet its commitment to the COVAX global pool in the fourth quarter of 2021 under the ‘Vaccine Maitri’ programme.
Mansukh Mandaviya asserted his emphases on vaccinating the Indian citizens as the topmost priority of the government. Mandaiya said, “India will be resuming the export of COVID-19 vaccines under Vaccine Maitri in order to fulfil the commitment of India towards COVAX in line with our motto of ‘Vasudhaiva Kutumbakam”. He also said that The surplus supply of vaccines will be used to fulfil India’s commitment towards the world for the collective fight against COVID-19.
A special appreciation was given to Mansukh Mandaviya for announcing the resume of crucial COVID19 vaccine shipments to COVAX in October. The Director, General Ghebreyesus said in a tweet with the hashtag vaccine equity since it is an important development in way of reaching the vaccination target.
Thank you Health Minister @mansukhmandviya for announcing #India will resume crucial #COVID19 vaccine shipments to #COVAX in October. This is an important development in support of reaching the 40% vaccination target in all countries by the end of the year. #VaccinEquity— Tedros Adhanom Ghebreyesus (@DrTedros) September 21, 2021
India stopped exporting COVID-19 vaccines in April this year following the second wave of the pandemic.
The minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the coming quarter from October-December. The cumulative doses administered so far across the country has crossed 81.7 crore.